BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3917866)

  • 1. Glycolipid receptor for human migration inhibitory factor: fucose and sialic acid are important for the human monocyte response to migration inhibitory factor.
    Liu DY; Yu SF; Remold HG; David JR
    Cell Immunol; 1985 Feb; 90(2):539-46. PubMed ID: 3917866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of sialic acid in the macrophage glycolipid receptor for MIF.
    Liu DY; Petschek KD; Remold HG; David JR
    J Immunol; 1980 Apr; 124(4):2042-7. PubMed ID: 6988512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage glycolipid receptors for human migration inhibitory factor (MIF): differentiated HL-60 cells exhibit MIF responsiveness and express surface glycolipids which both bind MIF and convert nonresponsive cells to responsiveness.
    Liu DY; Yu SF; Remold HG; David JR
    Cell Immunol; 1985 Feb; 90(2):605-13. PubMed ID: 3881194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further characterization of the putative glycolipid receptor for MIF: role of fucose associated with an acidic glycolipid.
    Higgins TJ; Liu DY; Remold HG; David JR
    Biochem Biophys Res Commun; 1980 Apr; 93(4):1259-65. PubMed ID: 6994721
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycolipid-dependent interaction between human migration-inhibitory factor and mononuclear phagocytes.
    Liu DY; Yu SF; Miller PA; Remold HG; David JR
    Cell Immunol; 1984 Oct; 88(2):350-60. PubMed ID: 6386184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-fucose, D-mannose, L-galactose, and their BSA conjugates stimulate macrophage migration.
    Takata I; Chida K; Gordon MR; Myrvik QN; Ricardo MJ; Kucera LS
    J Leukoc Biol; 1987 Mar; 41(3):248-56. PubMed ID: 3031190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediator-induced macrophage activation, as shown by enhanced cytotoxicity for tumor, requires macrophage surface fucose and sialic acid.
    Churchill WH; Wong C
    Cell Immunol; 1980 Oct; 55(2):490-8. PubMed ID: 6775822
    [No Abstract]   [Full Text] [Related]  

  • 8. Requirement for alpha-L-fucose on the macrophage membrane receptor for MIF.
    Remold HG
    J Exp Med; 1973 Nov; 138(5):1065-76. PubMed ID: 4583070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of macrophage-mediated cytotoxicity: role of target and effector cell fucose.
    Cameron DJ
    Immunol Lett; 1985; 11(1):39-44. PubMed ID: 4054947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibition induced by MDP, LPS, PMA, and MIF/MAF: reversal by macrophage migration enhancement factor (MEF), L-fucose, L-fucosyl BSA, D-mannose, and D-mannosyl BSA.
    Gordon MR; Chida K; Takata I; Myrvik QN
    J Leukoc Biol; 1987 Sep; 42(3):197-203. PubMed ID: 3305746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. I. Biochemical characterization and purification.
    Fahlbusch B; Tittel R
    Biomed Biochim Acta; 1986; 45(3):359-70. PubMed ID: 3518710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody.
    Thurman GB; Braude IA; Gray PW; Oldham RK; Stevenson HC
    J Immunol; 1985 Jan; 134(1):305-9. PubMed ID: 3917277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-mediated tumor cytotoxicity: role of macrophage surface sialic acid.
    Cameron DJ
    J Surg Oncol; 1983 Feb; 22(2):77-80. PubMed ID: 6823130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of macrophage migration inhibition factor by fucosylated glycolipid RM.
    Miura T; Handa S; Yamakawa T
    J Biochem; 1979 Sep; 86(3):773-6. PubMed ID: 389925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biochemistry and in vitro activity of soluble factors of activated lymphocytes.
    Sorg C
    Mol Cell Biochem; 1979 Dec; 28(1-3):149-67. PubMed ID: 393992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of monocyte fucose-receptors in T-cell fibronectin activity.
    Donson J; Mandy K; Feng ZH; Mandy S; Brown EJ; Godfrey HP
    Immunology; 1991 Nov; 74(3):473-7. PubMed ID: 1769694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of monosaccharides in the interaction of two lymphocyte mediators with their target cells.
    Rocklin RE
    J Immunol; 1976 Mar; 116(3):816-20. PubMed ID: 768376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermostability of human alpha-L-fucosidase. Relationship to fucosidosis and low-activity serum alpha-L-fucosidase.
    Alhadeff JA; Andrews-Smith GL
    Biochim Biophys Acta; 1980 Aug; 614(2):466-75. PubMed ID: 7407197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration.
    Hermanowski-Vosatka A; Mundt SS; Ayala JM; Goyal S; Hanlon WA; Czerwinski RM; Wright SD; Whitman CP
    Biochemistry; 1999 Sep; 38(39):12841-9. PubMed ID: 10504254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of terminal sugar residues of surface glycans in the metastatic potential of human hepatocarcinoma.
    Zhang Y; Zhang XY; Liu F; Qi HL; Chen HL
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):617-20. PubMed ID: 12458342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.